>

Todd Giorgio

  • Nanoparticles boost anti-cancer immunity

    Nanoparticles boost anti-cancer immunity

    by Bill Snyder The growth of epithelial ovarian cancer, one of the most lethal malignancies, is associated with the presence of tumor-associated macrophages (TAMs), white blood cells that can block the anti-cancer activity of the immune system and immunotherapy. Fortunately, TAMs can be “repolarized,” converted from immunosuppressive tumor-promoters to inflammatory tumor-fighters. Now, Associate Professor of Pharmacology Fiona Yull,... Read More

    Aug 16, 2022

  • Three engineering faculty win Vanderbilt grants to support early-stage pioneering research

    Three engineering faculty win Vanderbilt grants to support early-stage pioneering research

    Three engineering faculty members have received grants to support the early stages of pioneering research projects identified as likely candidates for further funding from federal, foundation and industry sponsors. Spring 2022 Seeding Success Grants were awarded to 14 faculty and are the second cycle of the internal early investment funding initiative. The grants, awarded to faculty spanning the... Read More

    Jun 29, 2022

  • Vanderbilt University

    Micelle “packets” deliver cancer drugs

    Vanderbilt researchers designed micelle “packets” to selectively deliver anti-cancer drugs to breast cancer cells. Read More

    Apr 8, 2015

  • Vanderbilt University

    Vanderbilt startup BioNanovations gets accelerated

    Vanderbilt graduate student Charleson Bell, who is the president of the high tech startup BioNanovations, is participating in a 12-week accelerator program in Silicon Valley specifically designed to encourage underrepresented tech entrepeneurs. Read More

    Aug 30, 2013